Ketodust Cream contains Ketoconazole 2% w/w, an imidazole antifungal agent effective against a broad spectrum of dermatophytes, yeasts, and molds. It is primarily indicated for the topical treatment of superficial fungal infections such as tinea corporis, tinea cruris, tinea pedis, and pityriasis versicolor. Ketoconazole exerts its antifungal activity by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to increased membrane permeability and ultimately fungal cell death. The cream formulation facilitates direct application to affected skin areas, ensuring localized therapeutic concentrations while minimizing systemic absorption and associated side effects. Ketodust Cream is typically applied once or twice daily to the cleansed and dried affected area for a duration determined by the severity and type of infection, usually ranging from 2 to 4 weeks. It is contraindicated in patients with known hypersensitivity to ketoconazole or any cream excipients. Common adverse reactions may include mild local irritation, itching, or erythema at the application site. Patients should avoid contact with eyes and mucous membranes. Ketodust Cream should be used with caution in pregnant or breastfeeding women, and only under medical supervision. Proper adherence to treatment duration is essential to prevent recurrence and resistance development.